Phase 2 Low-grade Glioma Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Dabrafenib and Trametinib for BRAF V600 Mutant Low-Grade Gliomas
BRAF V600 MutationLow-grade GliomaLow Grade Glioma of Brain+1 more
University of California, San Francisco96 enrolled5 locationsNCT07110246
Recruiting
Phase 1Phase 2
Phase 1/2 Study of Mirdametinib + Vinblastine for Newly Diagnosed/Previously Untreated PLGG + Activation of MAPK
Pediatric Low-grade Glioma
St. Justine's Hospital50 enrolled5 locationsNCT06666348
Recruiting
Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
Advanced Solid TumorLow-grade Glioma
Day One Biopharmaceuticals, Inc.141 enrolled35 locationsNCT04775485
Recruiting
Phase 2
FG001 in Subjects with Meningiomas or Presumed Low-Grade Gliomas Scheduled for Neurosurgery
MeningiomaGliomaLow-grade Glioma
Rigshospitalet, Denmark40 enrolled1 locationNCT06684795
Recruiting
Phase 2
Binimetinib in Patients With BRAF Fusion-positive Low-grade Glioma or Pancreatic Cancer (Perfume)
Pancreatic CancerLow-grade Glioma
National Cancer Center, Japan32 enrolled6 locationsNCT06159478
Recruiting
Phase 2Phase 3
Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery
Low-grade Glioma
West China Hospital250 enrolled1 locationNCT04316039